麻醉和呼吸设备市场规模、份额、趋势分析报告：按产品、地区、细分市场预测，2025-2030 年

Anesthesia And Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Respiratory Devices (), Anesthesia Devices), By Region, And Segment Forecasts, 2025 - 2030

出版日期: 2024年10月22日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

麻醉和呼吸设备市场成长和趋势：

Grand View Research, Inc.的最新报告显示，预计2030年全球麻醉和呼吸设备市场规模将达到759亿美元，2025年至2030年复合年增长率为5.9%。

呼吸系统疾病盛行率的增加、患者对缩短住院时间的偏好以及政府资助是关键驱动因素。此外，老化被认为是导致睡眠呼吸中止症的最大风险因素之一，因此预计将成为该行业影响力较大的渲染驱动因素。 COVID-19 大流行对该行业产生了重大影响。影响因细分市场而异。例如，由于机械人工呼吸器需求突然激增，人工呼吸器产业呈现快速成长。

但自2021年以来，这种需求有所下降，产业规模大幅萎缩。关于雾化器领域，由于使用吸入药物，人们对使用雾化器感到担忧，众所周知，吸入药物是病毒感染和免疫抑制的潜在原因。随着患者偏好转向缩短住院时间，麻醉和呼吸设备的采用增加预计将推动市场发展。根据美国医院协会的数据，大约 20% 的医疗保险受益人在出院后 30 天内重新入院。识别和减少可避免的再入院有望改善医疗保健安全并减少支出。

因此，政策制定者正在努力减少病患住院时间。在《病患保护与负担得起法案》中，国会于 2013 年启动了医院再入院减少计划 (HRRP)，根据该计划，医疗保险向再入院率高的医院支付费用，现在可能会受到处罚。随着该法的实施，许多医生和患者开始选择门诊输液帮浦和家用呼吸监视器等麻醉和呼吸设备。主要参与者正在努力开发先进设备以改善治疗。例如，2022年5月，Max Ventilator推出了一款由内建加湿器和氧气疗法组成的非侵入性（NIV）人工呼吸器。该设备易于使用、重量轻，且成本低于传统人工呼吸器。这些倡议预计将在未来几年推动产业成长。

麻醉和呼吸设备市场报告亮点：

就收益而言，由于慢性阻塞性肺病（COPD）、气喘、结核病等盛行率不断上升，呼吸设备业务在2024年占据最大的收益占有率。
由于外科手术数量的增加以及市场参与企业的各种技术进步，预计麻醉设备领域在预测期内将显着增长。
由于该地区存在主要参与者，北美在 2024 年占据了最大的收益占有率。
由于医疗保健支出的增加和患者意识的提高，预计亚太地区在预测期内将呈现最快的复合年增长率。

2023 年及 2030 年区域市场占有率分析
区域市场仪表板
全球区域市场简介
2018-2030年市场规模、预测趋势分析：
北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 挪威
- 瑞典
- 丹麦
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 泰国
拉丁美洲
- 巴西
- 阿根廷
中东/非洲
- 南非
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 科威特

第六章竞争状况

主要市场参与企业的最新趋势和影响分析
公司/竞争对手分类
2023年主要企业市场占有率/地位分析
公司简介
- General Electric Company
- Medtronic
- Teleflex Incorporated
- Koninklijke Philips NV
- Dragerwerk AG &CO. KGAA
- Getinge AB
- Smiths Group PLC
- Fisher &Paykel Healthcare Limited
- Masimo
- Braun Melsungen AG
- ResMed
- Inogen, Inc.
- Caire Medical（a subsidiary of NGK Spark Plug）
- DeVilbiss Healthcare（a subsidiary of Drive Medical）
- React Health（Respiratory Product Line from Invacare Corporation）
- O2 Concepts
- Nidek Medical Products, Inc.
- Omron Corporation
- GE Healthcare
- Allied Healthcare
- Vectura Group Plc.
- PARI Respiratory Equipment, Inc.
- Aerogen
- DeVilbiss Healthcare LLC
- Briggs Healthcare
- Beurer GmBH

简介目录图表

Product Code: 978-1-68038-557-1

Anesthesia And Respiratory Devices Market Growth & Trends:

The global anesthesia and respiratory devices market size is estimated to reach USD 75.9 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of respiratory diseases, patient preferences for a reduced hospital stay and supportive government funding are among the key driving factors. Furthermore, aging is considered one of the greatest risk factors for the development of sleep apnea disorders and is, therefore, expected to be a high-impact rendering driver for this industry. The COVID-19 pandemic had a significant impact on the industry. Different segments were impacted differently. For instance, the ventilators segment witnessed exponential growth owing to the sudden surge in the demand for mechanical ventilators.

However, this demand decreased post-2021, wherein the industry size decreased dramatically. Concerning the nebulizers segment, people were apprehensive to use nebulizers owing to the use of inhaled medications, which are considered a potential source of viral transmission and immunosuppression, which restricted the growth, but did not negatively impact the industry. Shifting the preference of patients towards reduced hospital stay is anticipated to increase the adoption of anesthesia and breathing instruments, thereby, driving the market. As per the American Hospital Association, approximately 20% of Medicare beneficiaries, when discharged from the hospital return within 30 days. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and reduce spending.

Hence, policymakers are striving to reduce the hospital stays of patients. In the Patient Protection and Affordable Act, Congress initiated the Hospital Readmission Reduction Program (HRRP), under which, Medicare is allowed to penalize hospitals for higher rates of readmissions since 2013. Due to the implementation of this act, many physicians and patients opt for anesthesia and breathing devices, such as ambulatory infusion pumps and home respiratory monitors. Key players are taking initiatives to develop advanced instruments to bring improvement in the treatment. For instance, in May 2022, Max Ventilator launched Non-Invasive (NIV) ventilators consisting of inbuilt humidifiers and oxygen therapy. The device is user-friendly as well as lightweight and is also priced lower than the traditional ventilators. Such initiatives are anticipated to propel industry growth in the coming years.

Anesthesia And Respiratory Devices Market Report Highlights:

In terms of revenue, the respiratory devices segment held the largest revenue share in 2024, owing to the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD), asthma, and tuberculosis, among others
The anesthesia devices segment is expected to grow significantly over the forecast period, owing to the rising number of surgeries and various technological advancements by market players
North America accounted for the largest revenue share in 2024 owing to the presence of major players in the region
Asia Pacific is expected to witness the fastest CAGR during the forecast period owing to increasing healthcare expenditure and awareness among patients.

Chapter 1. Research Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product outlook
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope

3.1. Market Dynamics
- 3.1.1. Market driver analysis
- 3.1.2. Market restraint analysis
- 3.1.3. Market Opportunities
3.2. Anesthesia and Respiratory Devices Market Analysis Tools
- 3.2.1. Industry Analysis - Porter's
  - 3.2.1.1. Supplier power
  - 3.2.1.2. Buyer power
  - 3.2.1.3. Substitution threat
  - 3.2.1.4. Threat of new entrant
  - 3.2.1.5. Competitive rivalry
- 3.2.2. PESTEL Analysis
  - 3.2.2.1. Political landscape
  - 3.2.2.2. Economic landscape
  - 3.2.2.3. Social landscape
  - 3.2.2.4. Technological landscape
  - 3.2.2.5. Environmental landscape
  - 3.2.2.6. Legal landscape
- 3.2.3. COVID-19 Impact Analysis

Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis

4.1. Product Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Brain Computer Interface Market by Product Type Outlook
- 4.3.1. Anesthesia Devices
  - 4.3.1.1. Anesthesia Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    - 4.3.1.1.1. Anesthesia Machines
      - 4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2018 - 2030 (USD Million)
      - 4.3.1.1.1.2. Anesthesia Workstation
        
        4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2018 - 2030 (USD Million)
      - 4.3.1.1.1.3. Anesthesia Delivery Station
        
        4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
        4.3.1.1.1.3.2. Portable Anesthesia Delivery Station
  - 4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
    - 4.3.1.1.2. Anesthesia Disposables
      - 4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2018 - 2030 (USD Million)
      - 4.3.1.1.2.2. Anesthesia Masks
        
        4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2018 - 2030 (USD Million)
      - 4.3.1.1.2.3. Anesthesia Accessories
        
        4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Respiratory Devices
  - 4.3.2.1. Respiratory devices market estimates and forecasts, 2018 - 2030 (USD Million)
    - 4.3.2.1.1. Respiratory Equipment's
      - 4.3.2.1.1.1. Respiratory Equipment's market estimates and forecasts, 2018 - 2030 (USD Million)
      - 4.3.2.1.1.2. Humidifiers
        
        4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
        4.3.2.1.1.2.2. Heat Humidifiers
  - 4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.8.3.1. Meter Dose Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, By Product

5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.5. North America
- 5.5.1. U.S.
  - 5.5.1.1. Key country dynamics
  - 5.5.1.2. Regulatory framework/ reimbursement structure
  - 5.5.1.3. Competitive scenario
  - 5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.2. Canada
  - 5.5.2.1. Key country dynamics
  - 5.5.2.2. Regulatory framework/ reimbursement structure
  - 5.5.2.3. Competitive scenario
  - 5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.3. Mexico
  - 5.5.3.1. Key country dynamics
  - 5.5.3.2. Regulatory framework/ reimbursement structure
  - 5.5.3.3. Competitive scenario
  - 5.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Europe
- 5.6.1. UK
  - 5.6.1.1. Key country dynamics
  - 5.6.1.2. Regulatory framework/ reimbursement structure
  - 5.6.1.3. Competitive scenario
  - 5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6.2. Germany
  - 5.6.2.1. Key country dynamics
  - 5.6.2.2. Regulatory framework/ reimbursement structure
  - 5.6.2.3. Competitive scenario
  - 5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6.3. France
  - 5.6.3.1. Key country dynamics
  - 5.6.3.2. Regulatory framework/ reimbursement structure
  - 5.6.3.3. Competitive scenario
  - 5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6.4. Italy
  - 5.6.4.1. Key country dynamics
  - 5.6.4.2. Regulatory framework/ reimbursement structure
  - 5.6.4.3. Competitive scenario
  - 5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6.5. Spain
  - 5.6.5.1. Key country dynamics
  - 5.6.5.2. Regulatory framework/ reimbursement structure
  - 5.6.5.3. Competitive scenario
  - 5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6.6. Norway
  - 5.6.6.1. Key country dynamics
  - 5.6.6.2. Regulatory framework/ reimbursement structure
  - 5.6.6.3. Competitive scenario
  - 5.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6.7. Sweden
  - 5.6.7.1. Key country dynamics
  - 5.6.7.2. Regulatory framework/ reimbursement structure
  - 5.6.7.3. Competitive scenario
  - 5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6.8. Denmark
  - 5.6.8.1. Key country dynamics
  - 5.6.8.2. Regulatory framework/ reimbursement structure
  - 5.6.8.3. Competitive scenario
  - 5.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Asia Pacific
- 5.7.1. Japan
  - 5.7.1.1. Key country dynamics
  - 5.7.1.2. Regulatory framework/ reimbursement structure
  - 5.7.1.3. Competitive scenario
  - 5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7.2. China
  - 5.7.2.1. Key country dynamics
  - 5.7.2.2. Regulatory framework/ reimbursement structure
  - 5.7.2.3. Competitive scenario
  - 5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7.3. India
  - 5.7.3.1. Key country dynamics
  - 5.7.3.2. Regulatory framework/ reimbursement structure
  - 5.7.3.3. Competitive scenario
  - 5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7.4. Australia
  - 5.7.4.1. Key country dynamics
  - 5.7.4.2. Regulatory framework/ reimbursement structure
  - 5.7.4.3. Competitive scenario
  - 5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7.5. South Korea
  - 5.7.5.1. Key country dynamics
  - 5.7.5.2. Regulatory framework/ reimbursement structure
  - 5.7.5.3. Competitive scenario
  - 5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7.6. Thailand
  - 5.7.6.1. Key country dynamics
  - 5.7.6.2. Regulatory framework/ reimbursement structure
  - 5.7.6.3. Competitive scenario
  - 5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Latin America
- 5.8.1. Brazil
  - 5.8.1.1. Key country dynamics
  - 5.8.1.2. Regulatory framework/ reimbursement structure
  - 5.8.1.3. Competitive scenario
  - 5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 5.8.2. Argentina
  - 5.8.2.1. Key country dynamics
  - 5.8.2.2. Regulatory framework/ reimbursement structure
  - 5.8.2.3. Competitive scenario
  - 5.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.9. MEA
- 5.9.1. South Africa
  - 5.9.1.1. Key country dynamics
  - 5.9.1.2. Regulatory framework/ reimbursement structure
  - 5.9.1.3. Competitive scenario
  - 5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 5.9.2. Saudi Arabia
  - 5.9.2.1. Key country dynamics
  - 5.9.2.2. Regulatory framework/ reimbursement structure
  - 5.9.2.3. Competitive scenario
  - 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 5.9.3. UAE
  - 5.9.3.1. Key country dynamics
  - 5.9.3.2. Regulatory framework/ reimbursement structure
  - 5.9.3.3. Competitive scenario
  - 5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 5.9.4. Kuwait
  - 5.9.4.1. Key country dynamics
  - 5.9.4.2. Regulatory framework/ reimbursement structure
  - 5.9.4.3. Competitive scenario
  - 5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Key company market share/position analysis, 2023
6.4. Company Profiles
- 6.4.1. General Electric Company
  - 6.4.1.1. Company Overview
  - 6.4.1.2. Financial Performance
  - 6.4.1.3. Product Benchmarking
  - 6.4.1.4. Strategic initiatives
- 6.4.2. Medtronic
  - 6.4.2.1. Company Overview
  - 6.4.2.2. Financial Performance
  - 6.4.2.3. Product Benchmarking
  - 6.4.2.4. Strategic initiatives
- 6.4.3. Teleflex Incorporated
  - 6.4.3.1. Company Overview
  - 6.4.3.2. Financial Performance
  - 6.4.3.3. Product Benchmarking
  - 6.4.3.4. Strategic initiatives
- 6.4.4. Koninklijke Philips N.V.
  - 6.4.4.1. Company Overview
  - 6.4.4.2. Financial Performance
  - 6.4.4.3. Product Benchmarking
  - 6.4.4.4. Strategic initiatives
- 6.4.5. Dragerwerk AG & CO. KGAA
  - 6.4.5.1. Company Overview
  - 6.4.5.2. Financial Performance
  - 6.4.5.3. Product Benchmarking
  - 6.4.5.4. Strategic initiatives
- 6.4.6. Getinge AB
  - 6.4.6.1. Company Overview
  - 6.4.6.2. Financial Performance
  - 6.4.6.3. Product Benchmarking
  - 6.4.6.4. Strategic initiatives
- 6.4.7. Smiths Group PLC
  - 6.4.7.1. Company Overview
  - 6.4.7.2. Financial Performance
  - 6.4.7.3. Product Benchmarking
  - 6.4.7.4. Strategic initiatives
- 6.4.8. Fisher & Paykel Healthcare Limited
  - 6.4.8.1. Company Overview
  - 6.4.8.2. Financial Performance
  - 6.4.8.3. Product Benchmarking
  - 6.4.8.4. Strategic initiatives
- 6.4.9. Masimo
  - 6.4.9.1. Company Overview
  - 6.4.9.2. Financial Performance
  - 6.4.9.3. Product Benchmarking
  - 6.4.9.4. Strategic initiatives
- 6.4.10. Braun Melsungen AG
  - 6.4.10.1. Company Overview
  - 6.4.10.2. Financial Performance
  - 6.4.10.3. Product Benchmarking
  - 6.4.10.4. Strategic initiatives
- 6.4.11. ResMed
  - 6.4.11.1. Company Overview
  - 6.4.11.2. Financial Performance
  - 6.4.11.3. Product Benchmarking
  - 6.4.11.4. Strategic initiatives
- 6.4.12. Inogen, Inc.
  - 6.4.12.1. Company Overview
  - 6.4.12.2. Financial Performance
  - 6.4.12.3. Product Benchmarking
  - 6.4.12.4. Strategic initiatives
- 6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
  - 6.4.13.1. Company Overview
  - 6.4.13.2. Financial Performance
  - 6.4.13.3. Product Benchmarking
  - 6.4.13.4. Strategic initiatives
- 6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical)
  - 6.4.14.1. Company Overview
  - 6.4.14.2. Financial Performance
  - 6.4.14.3. Product Benchmarking
  - 6.4.14.4. Strategic initiatives
- 6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
  - 6.4.15.1. Company Overview
  - 6.4.15.2. Financial Performance
  - 6.4.15.3. Product Benchmarking
  - 6.4.15.4. Strategic initiatives
- 6.4.16. O2 Concepts
  - 6.4.16.1. Company Overview
  - 6.4.16.2. Financial Performance
  - 6.4.16.3. Product Benchmarking
  - 6.4.16.4. Strategic initiatives
- 6.4.17. Nidek Medical Products, Inc.
  - 6.4.17.1. Company Overview
  - 6.4.17.2. Financial Performance
  - 6.4.17.3. Product Benchmarking
  - 6.4.17.4. Strategic initiatives
- 6.4.18. Omron Corporation
  - 6.4.18.1. Company Overview
  - 6.4.18.2. Financial Performance
  - 6.4.18.3. Product Benchmarking
  - 6.4.18.4. Strategic initiatives
- 6.4.19. GE Healthcare
  - 6.4.19.1. Company Overview
  - 6.4.19.2. Financial Performance
  - 6.4.19.3. Product Benchmarking
  - 6.4.19.4. Strategic initiatives
- 6.4.20. Allied Healthcare
  - 6.4.20.1. Company Overview
  - 6.4.20.2. Financial Performance
  - 6.4.20.3. Product Benchmarking
  - 6.4.20.4. Strategic initiatives
- 6.4.21. Vectura Group Plc.
  - 6.4.21.1. Company Overview
  - 6.4.21.2. Financial Performance
  - 6.4.21.3. Product Benchmarking
  - 6.4.21.4. Strategic initiatives
- 6.4.22. PARI Respiratory Equipment, Inc.
  - 6.4.22.1. Company Overview
  - 6.4.22.2. Financial Performance
  - 6.4.22.3. Product Benchmarking
  - 6.4.22.4. Strategic initiatives
- 6.4.23. Aerogen
  - 6.4.23.1. Company Overview
  - 6.4.23.2. Financial Performance
  - 6.4.23.3. Product Benchmarking
  - 6.4.23.4. Strategic initiatives
- 6.4.24. DeVilbiss Healthcare LLC
  - 6.4.24.1. Company Overview
  - 6.4.24.2. Financial Performance
  - 6.4.24.3. Product Benchmarking
  - 6.4.24.4. Strategic initiatives
- 6.4.25. Briggs Healthcare
  - 6.4.25.1. Company Overview
  - 6.4.25.2. Financial Performance
  - 6.4.25.3. Product Benchmarking
  - 6.4.25.4. Strategic initiatives
- 6.4.26. Beurer GmBH
  - 6.4.26.1. Company Overview
  - 6.4.26.2. Financial Performance
  - 6.4.26.3. Product Benchmarking
  - 6.4.26.4. Strategic initiatives

简介目录图表

List of Tables

Table 1 North America Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
Table 2 North America Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 3 U.S Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 4 Canada Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 5 Mexico Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 6 Europe Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
Table 7 Europe Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 8 UK Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 9 Germany Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 10 France Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 11 Italy Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 12 Spain Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 13 Sweden Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 14 Denmark Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 15 Norway Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 16 Asia Pacific Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
Table 17 Asia Pacific Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
Table 18 China Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 19 Japan Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 20 India Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 21 Australia Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 22 South Korea Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 23 Thailand Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 24 Latin America Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
Table 25 Latin America Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 26 Brazil Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 27 Argentina Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 28 MEA Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
Table 29 MEA Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 30 South Africa Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 31 Saudi Arabia Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 32 UAE Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
Table 33 Kuwait Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Aesthesia and respiratory devices market outlook
Fig. 9 Aesthesia and respiratory devices competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Aesthesia and respiratory devices market driver impact
Fig. 15 Aesthesia and respiratory devices market restraint impact
Fig. 16 Aesthesia and respiratory devices market strategic initiatives analysis
Fig. 17 Aesthesia and respiratory devices market: Product movement analysis
Fig. 18 Aesthesia and respiratory devices market: Product outlook and key takeaways
Fig. 19 Anesthesia devices market, 2018 - 2030 (USD Million)
Fig. 20 Anesthesia delivery machines market, 2018 - 2030 (USD Million)
Fig. 21 Anesthesia monitors market, 2018 - 2030 (USD Million)
Fig. 22 Anesthesia ventilators market, 2018 - 2030 (USD Million)
Fig. 23 Anesthesia workstations market, 2018 - 2030 (USD Million)
Fig. 24 Anesthesia disposables market, 2018 - 2030 (USD Million)
Fig. 25 Anesthesia disposables masks market, 2018 - 2030 (USD Million)
Fig. 26 Anesthesia disposable accessories market, 2018 - 2030 (USD Million)
Fig. 27 Respiratory devices market, 2018 - 2030 (USD Million)
Fig. 28 Positive airway pressure market, 2018 - 2030 (USD Million)
Fig. 29 Ventilators market, 2018 - 2030 (USD Million)
Fig. 30 Nebulizers market, 2018 - 2030 (USD Million)
Fig. 31 Humidifiers market, 2018 - 2030 (USD Million)
Fig. 32 Respiratory inhalers market, 2018 - 2030 (USD Million)
Fig. 33 Oxygen concentrators market, 2018 - 2030 (USD Million)
Fig. 34 Reusable resuscitators market, 2018 - 2030 (USD Million)
Fig. 35 Pulse oximeters market, 2018 - 2030 (USD Million)Anesthesia Devices
Fig. 36 Capnographs market, 2018 - 2030 (USD Million)
Fig. 37 Spirometers market, 2018 - 2030 (USD Million)
Fig. 38 Peak flow meters market, 2018 - 2030 (USD Million)
Fig. 39 Global aesthesia and respiratory devices market: Regional movement analysis
Fig. 40 Global aesthesia and respiratory devices market: Regional outlook and key takeaways
Fig. 41 Global anesthesia and respiratory devices market share and leading players
Fig. 42 North America market share and leading players
Fig. 43 Europe market share and leading players
Fig. 44 Asia Pacific market share and leading players
Fig. 45 Latin America market share and leading players
Fig. 46 Middle East & Africa market share and leading players
Fig. 47 North America: SWOT
Fig. 48 Europe SWOT
Fig. 49 Asia Pacific SWOT
Fig. 50 Latin America SWOT
Fig. 51 MEA SWOT
Fig. 52 North America market estimates and forecasts, 2018 - 2030
Fig. 53 U.S. market estimates and forecasts, 2018 - 2030
Fig. 54 Canada market estimates and forecasts, 2018 - 2030
Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
Fig. 56 Europe market estimates and forecasts, 2018 - 2030
Fig. 57 UK market estimates and forecasts, 2018 - 2030
Fig. 58 Germany market estimates and forecasts, 2018 - 2030
Fig. 59 France market estimates and forecasts, 2018 - 2030
Fig. 60 Italy market estimates and forecasts, 2018 - 2030
Fig. 61 Spain market estimates and forecasts, 2018 - 2030
Fig. 62 Denmark market estimates and forecasts, 2018 - 2030
Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
Fig. 64 Norway market estimates and forecasts, 2018 - 2030
Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 66 China market estimates and forecasts, 2018 - 2030
Fig. 67 Japan market estimates and forecasts, 2018 - 2030
Fig. 68 India market estimates and forecasts, 2018 - 2030
Fig. 69 Thailand market estimates and forecasts, 2018 - 2030
Fig. 70 South Korea market estimates and forecasts, 2018 - 2030
Fig. 71 Australia market estimates and forecasts, 2018 - 2030
Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
Fig. 73 Brazil market estimates and forecasts, 2018 - 2030
Fig. 74 Argentina market estimates and forecasts, 2018 - 2030
Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 76 South Africa market estimates and forecasts, 2018 - 2030
Fig. 77 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 78 UAE market estimates and forecasts, 2018 - 2030
Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 80 Market share of key market players- Brain Computer Interface market
Fig. 81 Key Company Categorization
Fig. 82 Company Market Share/Position Analysis, 2023
Fig. 83 Strategic Framework